Finally, in vitro studies have provided all available information on eCB-mediated synaptic plasticity in the mPFC or hippocampus in schizophrenia-relevant assays (e.g., adolescent cannabinoid exposure, mGluR and CB2 knockouts, and acute psychostimulant effects). The gene discussed is CNR2; the disease is schizophrenia.